Recent Finacing
Recent Raise
Raze Therapeutics discovers and develops oncology therapeutics targeting mitochondrial one‑carbon metabolism using a proprietary drug‑discovery platform to identify agents that selectively deprive solid tumors and hematologic malignancies of biomass precursors.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
